114 related articles for article (PubMed ID: 26846865)
1. Desmoteplase After Ischemic Stroke in Patients With Occlusion or High-Grade Stenosis in Major Cerebral Arteries.
Lindsberg PJ; Caso V
Stroke; 2016 Mar; 47(3):901-3. PubMed ID: 26846865
[No Abstract] [Full Text] [Related]
2. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.
Albers GW; von Kummer R; Truelsen T; Jensen JK; Ravn GM; Grønning BA; Chabriat H; Chang KC; Davalos AE; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A;
Lancet Neurol; 2015 Jun; 14(6):575-84. PubMed ID: 25937443
[TBL] [Abstract][Full Text] [Related]
3. Vascular occlusion enables selecting acute ischemic stroke patients for treatment with desmoteplase.
Fiebach JB; Al-Rawi Y; Wintermark M; Furlan AJ; Rowley HA; Lindstén A; Smyej J; Eng P; Warach S; Pedraza S
Stroke; 2012 Jun; 43(6):1561-6. PubMed ID: 22474060
[TBL] [Abstract][Full Text] [Related]
4. Safety and Tolerability of Desmoteplase Within 3 to 9 Hours After Symptoms Onset in Japanese Patients With Ischemic Stroke.
Mori E; Minematsu K; Nakagawara J; Hasegawa Y; Nagahiro S; Okada Y; Truelsen T; Lindsten A; Ogawa A; Yamaguchi T;
Stroke; 2015 Sep; 46(9):2549-54. PubMed ID: 26251244
[TBL] [Abstract][Full Text] [Related]
5. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.
Hacke W; Albers G; Al-Rawi Y; Bogousslavsky J; Davalos A; Eliasziw M; Fischer M; Furlan A; Kaste M; Lees KR; Soehngen M; Warach S;
Stroke; 2005 Jan; 36(1):66-73. PubMed ID: 15569863
[TBL] [Abstract][Full Text] [Related]
6. Desmoteplase 3 to 9 Hours After Major Artery Occlusion Stroke: The DIAS-4 Trial (Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke).
von Kummer R; Mori E; Truelsen T; Jensen JS; Grønning BA; Fiebach JB; Lovblad KO; Pedraza S; Romero JM; Chabriat H; Chang KC; Dávalos A; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A; Albers GW;
Stroke; 2016 Dec; 47(12):2880-2887. PubMed ID: 27803391
[TBL] [Abstract][Full Text] [Related]
7. The Desmoteplase in Acute Ischemic Stroke (DIAS) clinical trial program.
von Kummer R; Albers GW; Mori E;
Int J Stroke; 2012 Oct; 7(7):589-96. PubMed ID: 22989394
[TBL] [Abstract][Full Text] [Related]
8. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
9. Desmoteplase.
Paciaroni M; Medeiros E; Bogousslavsky J
Expert Opin Biol Ther; 2009 Jun; 9(6):773-8. PubMed ID: 19456211
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of desmoteplase in acute ischemic stroke patients: A systematic review and meta-analysis.
Li X; Ling L; Li C; Ma Q
Medicine (Baltimore); 2017 May; 96(18):e6667. PubMed ID: 28471961
[TBL] [Abstract][Full Text] [Related]
11. Thrombolytics in acute ischaemic stroke: historical perspective and future opportunities.
Röther J; Ford GA; Thijs VN
Cerebrovasc Dis; 2013; 35(4):313-9. PubMed ID: 23615379
[TBL] [Abstract][Full Text] [Related]
12. Desmoteplase as a potential treatment for cerebral ischaemia.
Patel R; Ispoglou S; Apostolakis S
Expert Opin Investig Drugs; 2014 Jun; 23(6):865-73. PubMed ID: 24766516
[TBL] [Abstract][Full Text] [Related]
13. Hyperacute therapy of ischemic stroke: intravenous thrombolysis.
Jahan R
Tech Vasc Interv Radiol; 2005 Jun; 8(2):81-6. PubMed ID: 16194755
[TBL] [Abstract][Full Text] [Related]
14. Recanalization and reperfusion therapies for acute ischemic stroke.
Molina CA; Alvarez-Sabín J
Cerebrovasc Dis; 2009; 27 Suppl 1():162-7. PubMed ID: 19342847
[TBL] [Abstract][Full Text] [Related]
15. Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis.
Maiser SJ; Georgiadis AL; Suri MF; Vazquez G; Lakshminarayan K; Qureshi AI
Int J Stroke; 2011 Feb; 6(1):25-32. PubMed ID: 21205237
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
[TBL] [Abstract][Full Text] [Related]
17. Thrombolysis in acute ischemic stroke.
Lang W; Domanovits H; Görzer H; Germann P; Gatterbauer E; Segall B
Acta Anaesthesiol Scand Suppl; 1997; 111():34-7. PubMed ID: 9420947
[No Abstract] [Full Text] [Related]
18. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset.
Furlan AJ; Eyding D; Albers GW; Al-Rawi Y; Lees KR; Rowley HA; Sachara C; Soehngen M; Warach S; Hacke W;
Stroke; 2006 May; 37(5):1227-31. PubMed ID: 16574922
[TBL] [Abstract][Full Text] [Related]
19. Desmoteplase for late treatment of stroke: still in the dark.
Hill MD; Menon BK
Lancet Neurol; 2015 Jun; 14(6):560-1. PubMed ID: 25937441
[No Abstract] [Full Text] [Related]
20. Desmoteplase in the treatment of acute ischemic stroke.
Dafer RM; Biller J
Expert Rev Neurother; 2007 Apr; 7(4):333-7. PubMed ID: 17425487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
